Loviride
Loviride is a non-nucleoside reverse transcriptase inhibitor ( NNRTI ) that entered phase III clinical trials in the late 1990s but failed to gain marketing approval because of poor potency . 
<triplet> Loviride <subj> non-nucleoside reverse transcriptase inhibitor (NNRTI) <obj> subject has role